Name | T1117 |
---|---|
Synonyms |
1H-Pyrazole-3-carboxamide, 5-[4'-[3-[[[3',6'-bis(dimethylamino)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl]carbonyl]amino]propyl][1,1'-biphenyl]-4-yl]-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-
5-{4'-[3-({[3',6'-Bis(dimethylamino)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-5-yl]carbonyl}amino)propyl]biphenyl-4-yl}-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide T1117 5-{4'-[3-({[3',6'-Bis(dimethylamino)-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthen]-5-yl]carbonyl}amino)propyl]-4-biphenylyl}-1-(2,4-dichlorophenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide |
Description | Tocrifluor 1117 (T1117), a fluorescent form of the cannabinoid CB1 receptor antagonist AM251, is a selective fluorescent GPR55 ligand. Tocrifluor 1117 is a potent tool for identifying the cellular location of cannabinoid receptors (including GPR55 in living tissues) (Ex/Em=543/590 nm)[1][2]. |
---|---|
Related Catalog | |
Target |
CB1 |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C56H53Cl2N7O5 |
Molecular Weight | 974.970 |
Exact Mass | 973.348511 |
LogP | 10.77 |
Index of Refraction | 1.678 |